BANNER UNIVERSITY MEDICAL CENTER PHX
1. Target Overview & Investment Thesis
BANNER UNIVERSITY MEDICAL CENTER PHX is a 656-bed safety-net/medicaid heavy in nan, AZ with $1.09B in net patient revenue and a -5.9% operating margin. The hospital serves a payer mix of 12.8% Medicare, 44.4% Medicaid, and 42.8% commercial.
Thesis: Undervalued. Our ML models identify $80.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.9% to 1.5% (+736bps).
| Net Revenue HCRIS | $1.09B |
| Current EBITDA COMPUTED | $-63.9M |
| Operating Margin COMPUTED | -5.9% |
| Occupancy HCRIS | 80.8% |
| Revenue / Bed COMPUTED | $1.7M |
| Net-to-Gross HCRIS | 24.9% |
| Distress Probability ML | 51.0% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -5.9% places it below the state median. Among 13 size-comparable peers (328-1312 beds), the median margin is -2.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (328-1312), prioritizing same-state peers. 13 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BANNER UNIVERSITY MEDICAL CENT (Target) | AZ | 656 | $1.09B | -5.9% |
| ST. JOSEPHS HOSPITAL & MEDICAL | AZ | 515 | $1.31B | -17.7% |
| PHOENIX CHILDRENS HOSPITAL | AZ | 352 | $1.26B | 6.0% |
| BANNER UNIVERSITY MED CENTER T | AZ | 533 | $1.03B | -4.6% |
| BANNER DESERT MEDICAL CENTER | AZ | 629 | $833.1M | 12.6% |
| TUCSON MEDICAL CENTER | AZ | 499 | $747.4M | -2.8% |
| CHANDLER REGIONAL MEDICAL CENT | AZ | 429 | $700.3M | -2.0% |
| BANNER THUNDERBIRD MEDICAL CEN | AZ | 539 | $674.4M | 8.4% |
| YUMA REGIONAL MEDICAL CENTER | AZ | 406 | $670.8M | 6.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $80.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $22.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $21.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $21.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $13.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $696K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-63.9M |
| + RCM Uplift | +$80.0M |
| Pro Forma EBITDA | $16.1M |
| Current Margin | -5.9% |
| Pro Forma Margin | 1.5% |
| WC Released (1x) | $41.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-98.4M | $378.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-98.4M | $384.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-88.5M | $616.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-88.5M | $646.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-108.2M | $10.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-108.2M | $-23.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (44.4%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 51.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 13 hospitals with 328-1312 beds
- Same-state prioritization (n=14)
- Comp margins: P25=-4.6% / P50=-2.0% / P75=6.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.